Literature DB >> 30720167

Elevated long non-coding RNA LINC00958 was associated with metastasis and unfavorable prognosis in gastric cancer.

W Wang1, Z-J Song, Y Wang, W-F Zhong, P Kang, Y Yang.   

Abstract

OBJECTIVE: To investigate the clinicopathological significance of long non-coding LINC00958 and its expression in gastric cancer (GC). PATIENTS AND METHODS: A total of 200 patients with GC whose sample tissues were enrolled. Total RNA was isolated using the TRIzol method followed by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) detection of LINC00958 on mRNA level. The correlation was analyzed using Chi-square test, between the LINC00958 expression versus clinicopathological variables, including age, gender, clinical stage, tumor size, TNM classification and overall prognosis. The Kaplan-Meier survival curve was used to assess the prognostic value of LINC00958 expression, after which univariate and multivariate analysis was carried out with the COX proportional hazard analysis.
RESULTS: LINC00958 was shown to be dramatically elevated in GC relative to normal controls. Elevated LINC00958 significantly correlated with lymph nodes metastases, distance metastasis, peritoneal dissemination, and peritumoral tissues infiltration (p<0.05). The Kaplan-Meier survival analysis showed that up-regulated LINC00958 was markedly associated with inferior overall survival (p<0.001). In addition, multivariate analysis highlighted that LINC00958 expression was an independent prognostic factor in GC.
CONCLUSIONS: Our observation revealed that elevated LINC00958 was significantly associated with metastasis and was an independent prognostic factor in GC, indicating that LINC00958 can serve as a novel prognostic predictor in GC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30720167     DOI: 10.26355/eurrev_201901_16872

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  10 in total

1.  LINC00958 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma cells.

Authors:  Biqi Wang; Duo Tang; Zijia Liu; Qian Wang; Shan Xue; Zijie Zhao; Dongdong Feng; Chao Sheng; Jintao Li; Zhixiang Zhou
Journal:  PLoS One       Date:  2021-05-18       Impact factor: 3.240

2.  Longnon-coding RNA BLACAT2 promotes gastric cancer progression via the miR-193b-5p/METTL3 pathway.

Authors:  Hao Hu; Qi Kong; Xiao-Xu Huang; Hao-Ran Zhang; Kai-Feng Hu; Yan Jing; Yang-Fan Jiang; Yue Peng; Long-Chao Wu; Qi-Sheng Fu; Li Xu; Ya-Bin Xia
Journal:  J Cancer       Date:  2021-04-02       Impact factor: 4.207

3.  LINC00958-MYC positive feedback loop modulates resistance of head and neck squamous cell carcinoma cells to chemo- and radiotherapy in vitro.

Authors:  Shanshan Huang; Zhengyu Zhan; Li Li; Hui Guo; Yangyang Yao; Miao Feng; Jun Deng; Jianping Xiong
Journal:  Onco Targets Ther       Date:  2019-07-24       Impact factor: 4.147

4.  LINC00958 Promotes The Malignancy Of Nasopharyngeal Carcinoma By Sponging microRNA-625 And Thus Upregulating NUAK1.

Authors:  Meijuan Chen; Zhina Xu; Yingyao Zhang; Xiujuan Zhang
Journal:  Onco Targets Ther       Date:  2019-11-06       Impact factor: 4.147

5.  M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.

Authors:  Xueliang Zuo; Zhiqiang Chen; Wen Gao; Yao Zhang; Jinguo Wang; Junfeng Wang; Ming Cao; Juan Cai; Jindao Wu; Xuehao Wang
Journal:  J Hematol Oncol       Date:  2020-01-08       Impact factor: 17.388

6.  Downregulation of LINC00958 inhibits proliferation, invasion and migration, and promotes apoptosis of colorectal cancer cells by targeting miR‑3619‑5p.

Authors:  Ye Sun; Yi Liu; Yun Cai; Pingping Han; Rui Wang; Lijun Cao; Shuixiang He
Journal:  Oncol Rep       Date:  2020-07-29       Impact factor: 3.906

7.  Identification of long non-coding RNA signatures for squamous cell carcinomas and adenocarcinomas.

Authors:  Suyan Tian; Mingbo Tang; Jialin Li; Chi Wang; Wei Liu
Journal:  Aging (Albany NY)       Date:  2020-12-09       Impact factor: 5.682

8.  LINC00958 promotes bladder cancer carcinogenesis by targeting miR-490-3p and AURKA.

Authors:  Hongtao Zhen; Peng Du; Qiang Yi; Xiaolong Tang; Tongqing Wang
Journal:  BMC Cancer       Date:  2021-10-26       Impact factor: 4.430

9.  STAT1-Induced Upregulation lncRNA LINC00958 Accelerates the Epithelial Ovarian Cancer Tumorigenesis by Regulating Wnt/β-Catenin Signaling.

Authors:  Min Xie; Qi Fu; Pin-Pin Wang; Yu-Lan Cui
Journal:  Dis Markers       Date:  2021-11-08       Impact factor: 3.434

10.  MYC/MAX-Activated LINC00958 Promotes Lung Adenocarcinoma by Oncogenic Transcriptional Reprogramming Through HOXA1 Activation.

Authors:  Tao Zhang; Fei Su; Yong-Bin Lu; Xiao-Ling Ling; Huan-Yu Dai; Tian-Ning Yang; Bin Zhang; Da Zhao; Xiao-Ming Hou
Journal:  Front Oncol       Date:  2022-02-09       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.